ACRTI-RADS scan for thyroid nodule characteristics include all except:
**Core Concept**
ACR-TIRADS (American College of Radiology-Thyroid Imaging Reporting and Data System) is a standardized reporting system for thyroid nodules on ultrasound. It evaluates the risk of malignancy based on various characteristics, including size, composition, echogenicity, margin, and echogenic foci.
**Why the Correct Answer is Right**
ACR-TIRADS assesses the risk of malignancy by assigning points to each characteristic, with higher scores indicating a higher risk. The system includes characteristics such as:
- Size: Nodules larger than 2 cm are assigned higher points.
- Composition: Solid or partially solid nodules are assigned higher points than purely cystic nodules.
- Echogenicity: Hyperechoic nodules are assigned higher points than hypoechoic or anechoic nodules.
- Margin: Irregular or lobulated margins are assigned higher points than smooth margins.
- Echogenic foci: Presence of microcalcifications, macrocalcifications, or rim calcifications is assigned higher points.
**Why Each Wrong Option is Incorrect**
**Option A:** Since ACR-TIRADS is a widely accepted and standardized reporting system, it is likely that the missing option is a characteristic that is not included in the system. However, without knowing the exact options, it's difficult to provide a specific explanation.
**Option B:** Assuming the missing option is a characteristic that is not included in ACR-TIRADS, it could be something like "vascularity" or "perinodular edema," which are not part of the system.
**Option C:** Another possibility is that the missing option is a characteristic that is not relevant to the risk of malignancy, such as "nodule shape" or "location within the thyroid gland."
**Option D:** Alternatively, the missing option could be a characteristic that is included in another thyroid nodule assessment system, but not in ACR-TIRADS.
**Clinical Pearl / High-Yield Fact**
When evaluating thyroid nodules on ultrasound, remember that ACR-TIRADS is a useful tool for assessing the risk of malignancy, but it should be used in conjunction with other clinical and radiological findings.
**Correct Answer:** A.